Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Sermorelin vs CJC-1295 vs Ipamorelin: Complete Comparison

The table below summarizes the sermorelin vs CJC-1295 vs ipamorelin comparison at a glance. Peptide Class GHRH analogue Modified GHRH analogue Modified GHRH + albumin binding Growth hormone secretagogue Receptor Target GHRH-R GHS-R1a (ghrelin receptor) Half-Li

This comparison does not assign a generated winner or score.

  • The table below summarizes the sermorelin vs CJC-1295 vs ipamorelin comparison at a glance.
  • Peptide Class
  • GHRH analogue
  • Modified GHRH analogue
  • Modified GHRH + albumin binding
  • Growth hormone secretagogue
  • Receptor Target
  • GHRH-R
  • GHS-R1a (ghrelin receptor)
  • Half-Life
  • 10-20 min
  • ~30 min
  • 6-8 days
  • ~2 hours
  • GH Release Pattern
  • Acute pulse, physiological
  • Acute pulse, slightly extended
  • Sustained elevation (blunts pulsatility)
  • Cortisol Effect
  • Minimal increase
  • No significant increase
  • Prolactin Effect
  • None
  • Appetite Effect
  • Minimal (unlike GHRP-6)
  • Clinical Data
  • FDA-approved (pediatric GHD, withdrawn)
  • Limited human PK data
  • Phase 2 data
  • Typical Administration
  • 1x daily (evening)
  • 1-3x daily
  • 1-2x weekly
More references

Related material

Comparison

Side-by-Side Comparison Table

Let’s compare Sermorelin, CJC-1295 (with/without DAC), and Ipamorelin across key factors: Feature Sermorelin (GHRH 1-29) CJC-1295 (No DAC) Mod GRF 1-29 CJC-1295 DAC Long-acting Ip…

View details →